October 10, 2018

CARDIALEN CLOSES $17 MILLION SERIES B FINANCING FOR HEART RHYTHM THERAPY

Cardialen is developing low-energy implantable defibrillation therapy designed to more gently restore normal heart rhythm


October 11, 2018

The Star Tribune features Cardialen and our revolutionary work to develop a low-energy implantable defibrillation therapy designed to more gently restore normal heart rhythm.

MINNEAPOLIS STARTUP CARDIALEN RAISES $17 MILLION IN VENTURE CAPITAL